相关实验视频

Updated: Jun 17, 2025

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

结直肠癌中KRAS突变和基因途径的关联:一项转录组和甲基组范围的研究以及对治疗的潜在影响

Farzana Jasmine¹, Armando Almazan¹, Yuliia Khamkevych¹

¹Institute for Population and Precision Health, Biological Sciences Division, The University of Chicago, Chicago, IL 60637, USA.

International journal of molecular sciences

|August 10, 2024

概括

结直肠癌 (CRC) 中的KRAS突变与显著的基因通路失调和甲基化变化相关. 这表明潜在的向疗法,包括抗CDKN2A治疗Villosol治疗KRAS突变CRC.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学遗传学是一个

背景情况:

基斯鼠肉瘤 (KRAS) 是结直肠癌 (CRC) 中最常发生突变的瘤基因.
之前的研究已经确定了微卫星不稳定性 (MSI),DNA促进物甲基化和CRC中的基因表达之间的联系.
了解KRAS突变对基因表达和甲基化的影响对于推进CRC精密医学至关重要.

研究的目的:

研究KRAS突变状态,基因表达特征和结直肠癌中的DNA甲基化模式之间的关联.
在KRAS突变CRC中确定精准医学方法的潜在治疗点和生物标志物.

主要方法:

全基因组基因表达分析在配对的CRC瘤和相邻的健康组织上进行.
基因组范围的DNA甲基化分析是在相同的配对组织样本上进行的.
统计分析了KRAS突变,基因表达和甲基化状态之间的相关性.

主要成果:

与没有突变的瘤相比,具有KRAS突变的结肠直肠瘤在主要基因通路中表现出明显更大的失调.
基因通路失调 (上调和下调) 与相应的DNA低甲基化和高甲基化有很强的相关性.
在KRAS突变的CRC瘤中,CDKN2A的上调更为明显,与细胞系研究中的5-FU耐药性相关.
蛋白质体通路基因在CRC显著上调,特别是在KRAS突变和MSI的瘤中.

结论:

KRAS突变状态显著影响结直肠癌的全球基因表达和甲基化场景.
在KRAS突变的CRC中CDKN2A上调表明抗CDKN2A疗法的潜在有效性,如Villosol.
观察到的蛋白酶体路径失调可能表明蛋白酶体抑制剂在特定CRC患者子组中的作用.

关键词:

这就是CDKN2A.欧洲农业基金会 (EGFR) 是一个基金.在KRAS突变中发生突变.在MSI中,它是MSI.在VEGF中,VEGF是VEGF.维洛索尔 (Villosol) 是一个城市.结直肠癌结直肠癌.蛋白酶体抑制剂是一种蛋白酶体抑制剂.

更多相关视频

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

相关概念视频

The Ras Gene

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Small GTPases - Ras and Rho

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Interactions Between Signaling Pathways

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...